A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.

Publié en août 2013 Chest

Bronchi wall and lumen volumes to assess airway remodeling in asthma by using CT: an innovative method?

Publication précédente

Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.

Publication suivante